Protalix Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $17,959 | $13,474 | $3,748 | $10,486 |
Gross Profit | 9,584 | 4,018 | 1,146 | 1,630 |
EBITDA | 4,471 | -1,586 | -4,021 | -5,339 |
EBIT | 4,142 | -1,905 | -4,343 | -5,652 |
Net Income | 3,236 | -2,203 | -4,595 | -6,044 |
Net Change In Cash | 17,959 | 13,474 | 3,748 | 10,486 |
Free Cash Flow | 4,018 | -3,782 | 3,589 | 3,345 |
Cash | 27,409 | 23,399 | 27,209 | 23,634 |
Basic Shares | 81,217 | 73,308 | 73,036 | 72,952 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $65,494 | $47,638 | $38,350 | $62,898 |
Gross Profit | 42,512 | 28,046 | 22,001 | 52,025 |
EBITDA | 11,651 | -10,782 | -18,943 | 4,450 |
EBIT | 10,460 | -11,868 | -20,061 | 3,148 |
Net Income | 8,312 | -14,927 | -33,985 | -14,892 |
Net Change In Cash | 65,494 | 47,638 | 38,350 | 62,898 |
Free Cash Flow | -2,467 | -25,628 | -11,744 | -26,761 |
Cash | 23,634 | 17,111 | 38,985 | 18,265 |
Basic Shares | 82,424 | 48,472 | 44,140 | 29,148 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.03 |
2024-06-30 | -$0.03 |
2024-03-31 | -$0.06 |
2023-12-31 | -$0.07 |
